PapersFlow Research Brief

Health Sciences · Medicine

Breast Lesions and Carcinomas
Research Guide

What is Breast Lesions and Carcinomas?

Breast lesions and carcinomas refer to pathological conditions in breast tissue ranging from benign abnormalities to malignant tumors, including invasive breast cancer, diagnosed and managed through imaging, biopsy, and histological analysis.

Research on breast lesions and carcinomas encompasses 49,500 works focused on pathology, imaging such as mammography and ultrasound, and treatments like lumpectomy and mastectomy. Key studies demonstrate that lumpectomy plus irradiation yields equivalent long-term survival to mastectomy when margins are clear, as shown in 20-year follow-ups. Histological grading provides prognostic value, with reproducibility improved in large long-term studies.

Topic Hierarchy

100%
graph TD D["Health Sciences"] F["Medicine"] S["Pathology and Forensic Medicine"] T["Breast Lesions and Carcinomas"] D --> F F --> S S --> T style T fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan
49.5K
Papers
N/A
5yr Growth
507.4K
Total Citations

Research Sub-Topics

Histological Grading in Breast Cancer

This sub-topic examines the prognostic value of histological grades in invasive breast carcinomas through long-term follow-up studies and standardization of grading systems like the Nottingham system. Researchers study correlations between grade, tumor biology, and patient outcomes to refine risk stratification.

15 papers

Ki67 Expression in Breast Cancer

This sub-topic investigates Ki67 as a proliferation marker in breast tumors, including assay standardization, cut-off values, and its role in subtype classification. Researchers analyze its prognostic and predictive utility across hormone receptor-positive and triple-negative cancers.

15 papers

Breast-Conserving Surgery versus Mastectomy

This sub-topic compares long-term outcomes of lumpectomy plus radiation versus total mastectomy in early-stage breast cancer through randomized trials. Researchers evaluate local recurrence, survival, and quality-of-life impacts.

15 papers

Sentinel Lymph Node Biopsy in Breast Cancer

This sub-topic covers lymphatic mapping techniques and the role of sentinel lymphadenectomy in staging axillary nodes, including trials on omitting completion dissection. Researchers study micrometastases detection and false-negative rates.

15 papers

Postoperative Radiotherapy after Breast-Conserving Surgery

This sub-topic analyzes meta-analyses of randomized trials on radiotherapy's impact on local recurrence and breast cancer mortality following lumpectomy. Researchers explore hypofractionation schedules and omission in low-risk cases.

15 papers

Why It Matters

Breast lesions and carcinomas affect diagnosis and treatment strategies in clinical oncology, with randomized trials establishing breast-conserving surgery as equivalent to mastectomy for survival outcomes. Fisher et al. (2002) reported in "Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer" that lumpectomy plus irradiation achieved similar 20-year survival rates to total mastectomy, influencing guidelines to prioritize cosmetic and functional preservation when feasible. Radiotherapy post-lumpectomy reduces 15-year breast cancer death rates, per meta-analyses of 10,801 women in 17 trials (Darby et al., 2011). Sentinel lymphadenectomy improves staging accuracy without routine axillary dissection in sentinel node-positive cases (Giuliano et al., 2011), reducing morbidity in early-stage patients.

Reading Guide

Where to Start

"Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer" by Fisher et al. (2002), as it provides foundational evidence on treatment equivalence with clear clinical implications for early invasive breast cancer management.

Key Papers Explained

Fisher et al. (2002) "Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer" and Veronesi et al. (2002) "Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer" both affirm long-term survival parity between conserving surgery and mastectomy. Clarke et al. (2005) "Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials" and Darby et al. (2011) "Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death" build on this by quantifying radiotherapy's recurrence reduction across trials. Elston and Ellis (1991) "pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer" supplies prognostic grading foundational to subtype strategies in Goldhirsch et al. (2011) "Strategies for subtypes—dealing with the diversity of breast cancer".

Paper Timeline

100%
graph LR P0["pathological prognostic factors ...
1991 · 6.1K cites"] P1["Twenty-Year Follow-up of a Rando...
2002 · 6.1K cites"] P2["Twenty-Year Follow-up of a Rando...
2002 · 4.4K cites"] P3["Effects of radiotherapy and of d...
2005 · 5.1K cites"] P4["Effect of radiotherapy after bre...
2011 · 3.8K cites"] P5["Strategies for subtypes—dealing ...
2011 · 3.8K cites"] P6["Ki67 expression in breast cancer
2016 · 4.4K cites"] P0 --> P1 P1 --> P2 P2 --> P3 P3 --> P4 P4 --> P5 P5 --> P6 style P1 fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan

Most-cited paper highlighted in red. Papers ordered chronologically.

Advanced Directions

Focus shifts to molecular markers like Ki67 in subtypes (Elkablawy et al., 2016) and refined nodal strategies avoiding full axillary dissection (Giuliano, 2011), with ESMO guidelines integrating these for diagnosis and follow-up (Aebi et al., 2010).

Papers at a Glance

Frequently Asked Questions

What is the prognostic value of histological grading in breast cancer?

Elston and Ellis (1991) in "pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up" established that morphological assessment of differentiation degree offers reliable prognostic information. This holds across studies despite past reproducibility concerns, now addressed through standardized methods. Grading is routinely used for risk stratification in invasive breast cancer.

How does Ki67 expression relate to breast cancer subtypes?

Ki67 proliferation index is highest in HER-2 and luminal-B subtypes, as found in Saudi breast cancer patients by Elkablawy et al. (2016) in "Ki67 expression in breast cancer". Levels exceed those in global literature, supporting its role alongside other markers for prognosis. Ki67 aids in predicting outcomes and guiding management decisions.

What are the long-term outcomes of lumpectomy versus mastectomy?

Veronesi et al. (2002) in "Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer" showed equivalent long-term survival rates for breast-conserving surgery and radical mastectomy in small tumors. Breast-conserving approaches are preferred when feasible. Fisher et al. (2002) confirmed this with irradiation post-lumpectomy matching mastectomy results.

What is the role of radiotherapy after breast-conserving surgery?

Darby et al. (2011) in "Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials" demonstrated reduced 10-year recurrence and 15-year mortality. Radiation is standard for margin-negative cases. It balances local control with survival benefits.

How does sentinel lymphadenectomy impact breast cancer staging?

Giuliano et al. (1994) in "Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer" showed intraoperative mapping identifies the sentinel node most likely containing metastases. This enhances staging accuracy. Giuliano (2011) in "Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis" supports omitting full dissection in select cases.

Open Research Questions

  • ? How can histological grading reproducibility be further standardized across global pathology labs?
  • ? What molecular factors beyond Ki67 best predict outcomes in HER-2 and luminal-B subtypes?
  • ? Under which precise conditions does radiotherapy provide maximal risk-benefit post-lumpectomy?
  • ? How do sentinel node mapping techniques evolve to minimize false negatives in diverse populations?

Research Breast Lesions and Carcinomas with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Breast Lesions and Carcinomas with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers